Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study
Hamidreza Mahmoudi, Ali Salehi Farid, Ali Nili, Dorsa Dayani, Soheil Tavakolpour, Tahereh Soori, Amir Teimourpour, Ahdie Isazade, Robabeh Abedini, Kamran Balighi, Maryam Daneshpazhooh
Topics & Concepts
MedicineRetrospective cohort studyRituximabPrednisoloneCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseInfectious disease (medical specialty)LymphomaAutoimmune Bullous Skin DiseasesAutoimmune and Inflammatory DisordersDrug-Induced Adverse Reactions